Frontal fibrosing alopecia (FFA) is a primary lymphocytic cicatricial alopecia with
characteristic clinical pattern of progressive frontotemporal hairline recession, perifollicular …

Frontal fibrosing alopecia is a scarring alopecia, the prevalence of which is increasing
worldwide since its first description in 1994. The reason for this emerging epidemic may be a …

Lichen planus (LP) is a chronic inflammatory and immune‐mediated disease that affects the
skin, hair, nails and mucous membranes. Although there is a broad clinical spectrum of …

Background To our knowledge, there are no large multicenter studies concerning frontal
fibrosing alopecia (FFA) that could give clues about its pathogenesis and best treatment …

Background Frontal fibrosing alopecia (FFA) is a chronic scarring alopecia with an
unpredictable evolution. There are no current classifications of this disease that may predict …

BACKGROUND: Frontal fibrosing alopecia (FFA) is a type of scarring hair loss primarily
observed in postmenopausal women and characterized by fronto-tempero-parietal hairline …

Both primary and secondary forms of cicatricial alopecia have been described. The hair
follicles are the specific target of inflammation in primary cicatricial alopecias. Hair follicles …

Background Guidelines for the treatment of frontal fibrosing alopecia (FFA) are limited, and
the literature on treatment modalities consists mostly of case reports and cohort studies …

Background Dutasteride has been proposed as an effective therapy for frontal fibrosing
alopecia (FFA). Objectives We sought to describe the therapeutic response to dutasteride …

Objective To characterize the clinicopathologic findings, comorbidities, and treatment
outcomes of women with frontal fibrosing alopecia. Patients and Methods Retrospective …